HCA Healthcare Future Growth
Future criteria checks 3/6
HCA Healthcare is forecast to grow earnings and revenue by 5.8% and 5.5% per annum respectively. EPS is expected to grow by 9.4% per annum. Return on equity is forecast to be 113.1% in 3 years.
Key information
5.8%
Earnings growth rate
9.4%
EPS growth rate
Healthcare earnings growth | 23.3% |
Revenue growth rate | 5.5% |
Future return on equity | 113.1% |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 78,657 | 6,661 | 5,173 | 10,848 | 20 |
12/31/2025 | 74,691 | 6,216 | 4,764 | 10,280 | 22 |
12/31/2024 | 70,571 | 5,831 | 5,245 | 10,159 | 21 |
9/30/2024 | 69,621 | 5,929 | 5,880 | 10,629 | N/A |
6/30/2024 | 68,347 | 5,738 | 4,888 | 9,593 | N/A |
3/31/2024 | 66,716 | 5,470 | 5,432 | 10,097 | N/A |
12/31/2023 | 64,968 | 5,242 | 4,687 | 9,431 | N/A |
9/30/2023 | 63,162 | 5,716 | 4,376 | 9,284 | N/A |
6/30/2023 | 61,920 | 5,771 | 4,933 | 9,825 | N/A |
3/31/2023 | 60,879 | 5,733 | 4,249 | 8,980 | N/A |
12/31/2022 | 60,233 | 5,643 | 4,127 | 8,522 | N/A |
9/30/2022 | 59,800 | 5,376 | 4,174 | 8,438 | N/A |
6/30/2022 | 60,105 | 6,511 | 3,673 | 7,695 | N/A |
3/31/2022 | 59,720 | 6,806 | 4,532 | 8,316 | N/A |
12/31/2021 | 58,752 | 6,956 | 5,382 | 8,959 | N/A |
9/30/2021 | 57,981 | 6,568 | -200 | 2,933 | N/A |
6/30/2021 | 56,016 | 4,967 | 640 | 3,373 | N/A |
3/31/2021 | 52,649 | 4,596 | 7,209 | 9,845 | N/A |
12/31/2020 | 51,533 | 3,754 | 6,397 | 9,232 | N/A |
9/30/2020 | 50,763 | 3,399 | 11,959 | 15,320 | N/A |
6/30/2020 | 50,146 | 3,343 | 10,718 | 14,729 | N/A |
3/31/2020 | 51,680 | 3,047 | 3,773 | 8,003 | N/A |
12/31/2019 | 51,336 | 3,505 | 3,444 | 7,602 | N/A |
9/30/2019 | 50,087 | 3,498 | 3,235 | 7,272 | N/A |
6/30/2019 | 48,844 | 3,645 | 3,123 | 6,867 | N/A |
3/31/2019 | 47,771 | 3,682 | 2,792 | 6,452 | N/A |
12/31/2018 | 46,677 | 3,787 | 3,188 | 6,761 | N/A |
9/30/2018 | 45,965 | 3,197 | 2,918 | 6,320 | N/A |
6/30/2018 | 45,210 | 2,864 | N/A | 5,607 | N/A |
3/31/2018 | 44,414 | 2,701 | N/A | 5,429 | N/A |
12/31/2017 | 43,614 | 2,216 | N/A | 5,426 | N/A |
9/30/2017 | 42,693 | 2,662 | N/A | 5,391 | N/A |
6/30/2017 | 42,267 | 2,854 | N/A | 5,589 | N/A |
3/31/2017 | 41,853 | 2,855 | N/A | 5,534 | N/A |
12/31/2016 | 41,490 | 2,890 | N/A | 5,653 | N/A |
9/30/2016 | 41,098 | 2,552 | N/A | 5,512 | N/A |
6/30/2016 | 40,684 | 2,383 | N/A | 5,407 | N/A |
3/31/2016 | 40,262 | 2,232 | N/A | 5,115 | N/A |
12/31/2015 | 39,678 | 2,129 | N/A | 4,734 | N/A |
9/30/2015 | 39,065 | 2,074 | N/A | 4,803 | N/A |
6/30/2015 | 38,429 | 2,143 | N/A | 4,830 | N/A |
3/31/2015 | 37,762 | 2,119 | N/A | 5,023 | N/A |
12/31/2014 | 36,918 | 1,875 | N/A | 4,448 | N/A |
9/30/2014 | 36,118 | 1,772 | N/A | 4,047 | N/A |
6/30/2014 | 35,354 | 1,619 | N/A | 3,819 | N/A |
3/31/2014 | 34,574 | 1,559 | N/A | 3,383 | N/A |
12/31/2013 | 34,182 | 1,556 | N/A | 3,680 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0J1R's forecast earnings growth (5.8% per year) is above the savings rate (2.1%).
Earnings vs Market: 0J1R's earnings (5.8% per year) are forecast to grow slower than the UK market (14.6% per year).
High Growth Earnings: 0J1R's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0J1R's revenue (5.5% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0J1R's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0J1R's Return on Equity is forecast to be very high in 3 years time (113.1%).